Literature DB >> 9437705

The role of the circulation in processing pro-brain natriuretic peptide (proBNP) to amino-terminal BNP and BNP-32.

P J Hunt1, E A Espiner, M G Nicholls, A M Richards, T G Yandle.   

Abstract

Human proBNP (purified from cardiac tissue) was incubated at 37 degrees C in whole blood, serum and plasma and the products analyzed by size exclusion high pressure liquid chromatography and radioimmunoassay (RIA). In addition to RIAs for BNP-32 and NT-proBNP(1-13), a newly developed RIA for proBNP(62-76) was also used to identify the peptides. Incubation with serum resulted in the formation of a 9 kDa and a 3 kDa peptide, consistent with the N-terminal and the C-terminal peptides of the propeptide. Minimal processing of proBNP was seen in blood or plasma, suggesting that the circulation does not play a major role in the activation of proBNP. Analysis of degradation products of human proBNP using site directed specific antisera indicates that removal of N-terminal amino acids from proBNP occurs in serum. These findings support the view that the "high molecular weight BNP-32" previously identified in human plasma comprises amino-terminal deleted forms, and is unlikely to be intact proBNP(1-108).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9437705     DOI: 10.1016/s0196-9781(97)00245-3

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  7 in total

1.  Transient elevation of NT-pro-BNP as a predictor for myocardial ischemia.

Authors:  Sebastian Szardien; Holger M Nef; Helge Möllmann; Sandra Voss; Christian Troidl; Christoph Liebetrau; Andreas Rolf; Johannes Rixe; Michael Weber; Christian W Hamm
Journal:  Clin Res Cardiol       Date:  2010-09-07       Impact factor: 5.460

2.  NT pro B type natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy.

Authors:  Neeraj Parakh; Sameer Mehrotra; Sandeep Seth; S Ramakrishnan; Shyam S Kothari; Balram Bhargava; V K Bahl
Journal:  Indian Heart J       Date:  2015-03-13

3.  Depressive symptoms affect the relationship of N-terminal pro B-type natriuretic peptide to cardiac event-free survival in patients with heart failure.

Authors:  Eun Kyeung Song; Debra K Moser; Susan K Frazier; Seongkum Heo; Misook L Chung; Terry A Lennie
Journal:  J Card Fail       Date:  2010-03-19       Impact factor: 5.712

4.  Comparison of pleural fluid N-terminal pro-brain natriuretic peptide and brain natriuretic-32 peptide levels.

Authors:  Ann C Long; Hollis R O'Neal; Suiwei Peng; Kirk B Lane; Richard W Light
Journal:  Chest       Date:  2010-02-05       Impact factor: 9.410

Review 5.  Molecular forms of natriuretic peptides in heart failure and their implications.

Authors:  Ye Olivia Xu-Cai; Qingyu Wu
Journal:  Heart       Date:  2009-05-17       Impact factor: 5.994

6.  Nonheart failure-associated elevation of amino terminal pro-brain natriuretic peptide in the setting of sepsis.

Authors:  Simona L Bar; Elizabeth Swiggum; Lynn Straatman; Andrew Ignaszewski
Journal:  Can J Cardiol       Date:  2006-03-01       Impact factor: 5.223

Review 7.  B-Type Natriuretic Peptide as a Significant Brain Biomarker for Stroke Triaging Using a Bedside Point-of-Care Monitoring Biosensor.

Authors:  Dorin Harpaz; Raymond C S Seet; Robert S Marks; Alfred I Y Tok
Journal:  Biosensors (Basel)       Date:  2020-08-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.